The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: An overview

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 6, 2013, Pages 1783-1787

  Treglia, Giorgio ^a   Muoio, Barbara ^b   Giovanella, Luca ^c   Salvatori, Massimo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Nuclear medicine; PET CT; Positron emission tomography; Thyroid; Thyroid carcinoma

Indexed keywords

CALCITONIN; FLUORODEOXYGLUCOSE F 18; IODINE 124; IODINE 131; THYROGLOBULIN;

CALCITONIN BLOOD LEVEL; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIATED THYROID CANCER; DOSIMETRY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN BLOOD LEVEL; THYROID INCIDENTALOMA; TREATMENT PLANNING;

BIOPSY, FINE-NEEDLE; FLUORODEOXYGLUCOSE F18; HUMANS; MULTIMODAL IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; THYROIDECTOMY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; WHOLE BODY IMAGING;

EID: 84877873957     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2205-2     Document Type: Review

References (34)

1. Treglia G, Cason E, Fagioli G (2010) Recent applications of nuclear medicine in diagnostics (first part). Ital J Med 4:84-91
2. Abraham T, Schöder H (2011) Thyroid cancer-indications and opportunities for positron emission tomography/computed tomography imaging. Semin Nucl Med 41:121-138
3. Giovanella L (2012) Positron emission tomography/computed tomography in patients treated for differentiated thyroid carcinomas. Expert Rev Endocrinol Metab 7:35-43
4. Feine U, Lietzenmayer R, Hanke JP, Wöhrle H, Müller-Schauenburg W (1995) 18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I. Nuklearmedizin 34:127-134
5. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
6. Dong MJ, Liu ZF, Zhao K et al (2009) Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis. Nucl Med Commun 30:639-650
7. Ma C, Xie J, Lou Y, Gao Y, Zuo S, Wang X (2010) The role of TSH for 18F-FDG-PET in the diagnosis of recurrence and metastases of differentiated thyroid carcinoma with elevated thyroglobulin and negative scan: a meta-analysis. Eur J Endocrinol 163:177-183
8. Giovanella L, Ceriani L, De Palma D, Suriano S, Castellani M, Verburg FA (2012) Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas. Head Neck 34:626-631
9. Robbins RJ, Wan Q, Grewal RK et al (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-d-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91:498-505
10. Freudenberg LS, Jentzen W, Stahl A, Bockisch A, Rosenbaum-Krumme SJ (2011) Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 38(Suppl 1):S48-S56
11. Freudenberg LS, Antoch G, Frilling A et al (2008) Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging 35:950-957
12. Grabellus F, Nagarajah J, Bockisch A, Schmid KW, Sheu SY (2012) Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Clin Nucl Med 37:121-127
13. Pryma DA, Schöder H, Gönen M, Robbins RJ, Larson SM, Yeung HW (2006) Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients. J Nucl Med 47:1260-1266
14. Poisson T, Deandreis D, Leboulleux S et al (2010) 18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer. Eur J Nucl Med Mol Imaging 37:2277-2285
15. American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565-612
16. Treglia G, Rufini V, Salvatori M, Giordano A, Giovanella L (2012) PET imaging in recurrent medullary thyroid carcinoma. Int J Mol Imaging 2012:324686
17. Rufini V, Treglia G, Perotti G, Leccisotti L, Calcagni ML, Rubello D (2008) Role of PET in medullary thyroid carcinoma. Minerva Endocrinol 33:67-73
18. Treglia G, Villani MF, Giordano A, Rufini V (2012) Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis. Endocrine. doi: 10.1007/s12020-012-9671-6
19. Treglia G, Cocciolillo F, Di Nardo F et al (2012) Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis. Acad Radiol 19:1290-1299
20. Treglia G, Castaldi P, Villani MF et al (2012) Comparison of 18F-DOPA, 18F-FDG and 68 Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 39:569-580
21. Conry BG, Papathanasiou ND, Prakash V et al (2010) Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 37:49-57
22. Naswa N, Sharma P, Suman S et al (2012) Prospective evaluation of 68 Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT. Nucl Med Commun 33:766-774
23. Treglia G, Rindi G, Rufini V (2012) Expression of somatostatin receptors may guide the use of somatostatin receptor imaging and therapy in differentiated thyroid cancer. Hormones 11:230-232
24. Treglia G, Castaldi P, Villani MF et al (2012) Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature. Recent Results Cancer Res 194:385-393
25. Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF (2011) The role of [(18) F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117:4582-4594
26. Deandreis D, Al Ghuzlan A, Auperin A et al (2012) Is (18)f- fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid 22:165-172
27. Giovanella L, Suriano S, Maffioli M, Ceriani L (2011) 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology. Clin Endocrinol 74:644-648
28. Jin J, McHenry CR (2012) Thyroid incidentaloma. Best Pract Res Clin Endocrinol Metab 26:83-96
29. Iyer NG, Shaha AR, Silver CE et al (2010) Thyroid incidentalomas: to treat or not to treat. Eur Arch Otorhinolaryngol 267:1019-1026
30. Bonabi S, Schmidt F, Broglie MA, Haile SR, Stoeckli SJ (2012) Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact. Eur Arch Otorhinolaryngol. doi: 10.1007/s00405-012-1941-7
31. Rothman IN, Middleton L, Stack BC Jr, Bartel T, Riggs AT, Bodenner DL (2011) Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism. Eur Arch Otorhinolaryngol 268:1501-1504
32. Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L (2012) Risk of malignancy in thyroid incidentalomas detected by (18)f-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 22:918-925
33. Bertagna F, Treglia G, Piccardo A, Giubbini R (2012) Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab. doi: 10.1210/jc.2012-2390
34. Treglia G, Giovanella L, Bertagna F, Di Franco D, Salvatori M (2012) A pooled analysis to calculate the prevalence and risk of malignancy of thyroid incidentalomas detected by Fluorine-18-Fluorodeoxyglucose positron emission tomography. Thyroid. doi: 10.1089/thy.2012-0216